Saroglitazar treatment prevents NASH, eliminates hepatocyte ballooning, and significantly improves serum LFTs, lipids and insulin resistance in DIAMOND(tm) mice compared to pioglitazone benchmark
暂无分享,去创建一个
P. Bedossa | A. Sanyal | Suresh R. Giri | Mukul R Jain | R. Caffrey | Prasanna K. Santhekadur | B. Philip | Jonathon Marioneaux